栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/05/25 | 1,681 | 1,683 | 1,638 | 1,638 | -38 | -2.3% | 91,700 |
| 2022/05/24 | 1,673 | 1,688 | 1,660 | 1,676 | -1 | -0.1% | 112,400 |
| 2022/05/23 | 1,663 | 1,682 | 1,652 | 1,677 | +37 | +2.3% | 131,500 |
| 2022/05/20 | 1,633 | 1,641 | 1,620 | 1,640 | +14 | +0.9% | 79,500 |
| 2022/05/19 | 1,603 | 1,627 | 1,597 | 1,626 | +9 | +0.6% | 120,500 |
| 2022/05/18 | 1,608 | 1,631 | 1,597 | 1,617 | +9 | +0.6% | 117,500 |
| 2022/05/17 | 1,567 | 1,613 | 1,564 | 1,608 | +26 | +1.6% | 164,800 |
| 2022/05/16 | 1,623 | 1,623 | 1,573 | 1,582 | -14 | -0.9% | 129,700 |
| 2022/05/13 | 1,552 | 1,602 | 1,547 | 1,596 | +38 | +2.4% | 134,300 |
| 2022/05/12 | 1,572 | 1,591 | 1,552 | 1,558 | -90 | -5.5% | 200,900 |
| 2022/05/11 | 1,648 | 1,658 | 1,635 | 1,648 | -7 | -0.4% | 96,300 |
| 2022/05/10 | 1,605 | 1,664 | 1,605 | 1,655 | +49 | +3.1% | 172,800 |
| 2022/05/09 | 1,634 | 1,642 | 1,606 | 1,606 | -25 | -1.5% | 120,400 |
| 2022/05/06 | 1,642 | 1,648 | 1,618 | 1,631 | -11 | -0.7% | 137,400 |
| 2022/05/02 | 1,606 | 1,650 | 1,606 | 1,642 | -80 | -4.6% | 251,300 |
| 2022/04/28 | 1,692 | 1,724 | 1,692 | 1,722 | +39 | +2.3% | 109,900 |
| 2022/04/27 | 1,684 | 1,684 | 1,666 | 1,683 | -27 | -1.6% | 225,500 |
| 2022/04/26 | 1,710 | 1,720 | 1,700 | 1,710 | +10 | +0.6% | 64,300 |
| 2022/04/25 | 1,692 | 1,715 | 1,685 | 1,700 | +8 | +0.5% | 102,800 |
| 2022/04/22 | 1,696 | 1,706 | 1,686 | 1,692 | -31 | -1.8% | 60,400 |
| 2022/04/21 | 1,688 | 1,723 | 1,688 | 1,723 | +40 | +2.4% | 103,000 |
| 2022/04/20 | 1,694 | 1,704 | 1,675 | 1,683 | +17 | +1% | 68,800 |
| 2022/04/19 | 1,671 | 1,682 | 1,661 | 1,666 | +2 | +0.1% | 72,500 |
| 2022/04/18 | 1,692 | 1,705 | 1,644 | 1,664 | -45 | -2.6% | 125,400 |
| 2022/04/15 | 1,706 | 1,716 | 1,698 | 1,709 | -9 | -0.5% | 113,900 |
| 2022/04/14 | 1,711 | 1,718 | 1,705 | 1,718 | +6 | +0.4% | 54,500 |
| 2022/04/13 | 1,704 | 1,721 | 1,699 | 1,712 | +13 | +0.8% | 107,400 |
| 2022/04/12 | 1,714 | 1,721 | 1,698 | 1,699 | -29 | -1.7% | 89,800 |
| 2022/04/11 | 1,751 | 1,758 | 1,712 | 1,728 | -23 | -1.3% | 117,800 |
| 2022/04/08 | 1,747 | 1,762 | 1,734 | 1,751 | +28 | +1.6% | 213,700 |
| 2022/04/07 | 1,740 | 1,740 | 1,717 | 1,723 | -25 | -1.4% | 48,300 |
| 2022/04/06 | 1,751 | 1,761 | 1,745 | 1,748 | -14 | -0.8% | 48,600 |
| 2022/04/05 | 1,764 | 1,766 | 1,748 | 1,762 | -1 | -0.1% | 86,200 |
| 2022/04/04 | 1,731 | 1,773 | 1,731 | 1,763 | +28 | +1.6% | 69,000 |
| 2022/04/01 | 1,718 | 1,746 | 1,700 | 1,735 | +8 | +0.5% | 57,500 |
| 2022/03/31 | 1,770 | 1,771 | 1,727 | 1,727 | -54 | -3% | 116,200 |
| 2022/03/30 | 1,805 | 1,832 | 1,766 | 1,781 | -27 | -1.5% | 104,700 |
| 2022/03/29 | 1,806 | 1,811 | 1,788 | 1,808 | +4 | +0.2% | 101,000 |
| 2022/03/28 | 1,801 | 1,808 | 1,790 | 1,804 | +3 | +0.2% | 53,600 |
| 2022/03/25 | 1,785 | 1,803 | 1,779 | 1,801 | +14 | +0.8% | 61,300 |
| 2022/03/24 | 1,773 | 1,787 | 1,762 | 1,787 | -3 | -0.2% | 57,700 |
| 2022/03/23 | 1,764 | 1,794 | 1,747 | 1,790 | +38 | +2.2% | 99,100 |
| 2022/03/22 | 1,788 | 1,788 | 1,743 | 1,752 | -33 | -1.8% | 104,700 |
| 2022/03/18 | 1,772 | 1,788 | 1,763 | 1,785 | +7 | +0.4% | 119,300 |
| 2022/03/17 | 1,747 | 1,789 | 1,740 | 1,778 | +51 | +3% | 106,700 |
| 2022/03/16 | 1,752 | 1,752 | 1,723 | 1,727 | -10 | -0.6% | 78,500 |
| 2022/03/15 | 1,728 | 1,748 | 1,720 | 1,737 | +1 | +0.1% | 49,100 |
| 2022/03/14 | 1,727 | 1,751 | 1,724 | 1,736 | +30 | +1.8% | 93,900 |
| 2022/03/11 | 1,725 | 1,726 | 1,697 | 1,706 | -36 | -2.1% | 66,700 |
| 2022/03/10 | 1,742 | 1,748 | 1,730 | 1,742 | +40 | +2.4% | 71,300 |
601～
650
件表示中 / 6825件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 232,200円 | +7.6% | +57.5% | 2.28% | 17.95倍 | 1.76倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ネクセラファーマ | 121,300円 | +197.7% | - | 0.00% | 49.57倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ＪＣＲファーマ | 67,900円 | -3.7% | -36.7% | 2.95% | 23.03倍 | 1.51倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| サンバイオ | 101,300円 | - | - | 0.00% | - | 51.01倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
